Patient-Derived Xenograft Models in Cancer Research

por van Weerden, Wytske M.
Publicado 2021

Awe and anxiety for cancer cells: connecting scientists and patients in a holistic approach of metastasis research

por Bronkhorst, Hildert, van Weerden, Wytske M., Bunnik, Eline M., Zwart, Hub
Publicado 2023

The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research

por Ruigrok, Eline A.M., van Weerden, Wytske M., Nonnekens, Julie, de Jong, Marion
Publicado 2019

Correction to: Role of the DNA damage response in prostate cancer formation, progression and treatment

por Zhang, Wenhao, van Gent, Dik C., Incrocci, Luca, van Weerden, Wytske M., Nonnekens, Julie
Publicado 2019

Role of the DNA damage response in prostate cancer formation, progression and treatment

por Zhang, Wenhao, van Gent, Dik C., Incrocci, Luca, van Weerden, Wytske M., Nonnekens, Julie
Publicado 2019

Bypass Mechanisms of the Androgen Receptor Pathway in Therapy-Resistant Prostate Cancer Cell Models

por Marques, Rute B., Dits, Natasja F., Erkens-Schulze, Sigrun, van Weerden, Wytske M., Jenster, Guido
Publicado 2010

Radiolabeled Bombesin Analogs

por Mansi, Rosalba, Nock, Berthold A., Dalm, Simone U., Busstra, Martijn B., van Weerden, Wytske M., Maina, Theodosia
Publicado 2021

Apalutamide Sensitizes Prostate Cancer to Ionizing Radiation via Inhibition of Non-Homologous End-Joining DNA Repair

por Zhang, Wenhao, Liao, Chen-Yi, Chtatou, Hajar, Incrocci, Luca, van Gent, Dik C., van Weerden, Wytske M., Nonnekens, Julie
Publicado 2019

Modeling Prostate Cancer Treatment Responses in the Organoid Era: 3D Environment Impacts Drug Testing

por Van Hemelryk, Annelies, Mout, Lisanne, Erkens-Schulze, Sigrun, French, Pim J., van Weerden, Wytske M., van Royen, Martin E.
Publicado 2021

Modulation of Androgen Receptor Signaling in Hormonal Therapy-Resistant Prostate Cancer Cell Lines

por Marques, Rute B., Dits, Natasja F., Erkens-Schulze, Sigrun, van IJcken, Wilfred F. J., van Weerden, Wytske M., Jenster, Guido
Publicado 2011

Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor

por Hassani, Mahmoud, Hajari Taheri, Fatemeh, Sharifzadeh, Zahra, Arashkia, Arash, Hadjati, Jamshid, van Weerden, Wytske M., Abdoli, Shahriyar, Modarressi, Mohammad Hossein, Abolhassani, Mohsen
Publicado 2020

Overexpression of Full-Length ETV1 Transcripts in Clinical Prostate Cancer Due to Gene Translocation

por Gasi, Delila, van der Korput, Hetty A., Douben, Hannie C., de Klein, Annelies, de Ridder, Corrina M., van Weerden, Wytske M., Trapman, Jan
Publicado 2011

Characterization of Heterogeneous Prostate Tumors in Targeted Pten Knockout Mice

por Korsten, Hanneke, Ziel-van der Made, Angelique C. J., van Weerden, Wytske M., van der Kwast, Theo, Trapman, Jan, Van Duijn, Petra W.
Publicado 2016

Cell Line Characteristics Predict Subsequent Resistance to Androgen Receptor-Targeted Agents (ARTA) in Preclinical Models of Prostate Cancer

por Moll, Jan Matthijs, Teubel, Wilma J., Erkens, Sigrun E., Jozefzoon-Agai, Ashraf, Dits, Natasja F., van Rijswijk, Angelique, Jenster, Guido W., van Weerden, Wytske M.
Publicado 2022

GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches

por Verhoeven, Marjolein, Ruigrok, Eline A. M., van Leenders, Geert J. L. H., van den Brink, Lilian, Balcioglu, Hayri E., van Weerden, Wytske M., Dalm, Simone U.
Publicado 2023

Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids

por Van Hemelryk, Annelies, Erkens-Schulze, Sigrun, Lim, Lifani, de Ridder, Corrina M. A., Stuurman, Debra C., Jenster, Guido W., van Royen, Martin E., van Weerden, Wytske M.
Publicado 2023

Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response

por Zhang, Wenhao, van Weerden, Wytske M., de Ridder, Corrina M. A., Erkens‐Schulze, Sigrun, Schönfeld, Edgar, Meijer, Titia G., Kanaar, Roland, van Gent, Dik C., Nonnekens, Julie
Publicado 2018

Abiraterone switches castration‐resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling

por Moll, J. Matthijs, Hofland, Johannes, Teubel, Wilma J., de Ridder, Corina M. A., Taylor, Angela E., Graeser, Ralph, Arlt, Wiebke, Jenster, Guido W., van Weerden, Wytske M.
Publicado 2022

A bypass mechanism of abiraterone‐resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signaling

por Moll, Jan M., Kumagai, Jinpei, van Royen, Martin E., Teubel, Wilma J., van Soest, Robert J., French, Pim J., Homma, Yukio, Jenster, Guido, de Wit, Ronald, van Weerden, Wytske M.
Publicado 2019

Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment

por Ruigrok, Eline A. M., Verkaik, Nicole S., de Blois, Erik, de Ridder, Corrina, Stuurman, Debra, Roobol, Stefan J., Van Gent, Dik C., de Jong, Marion, Van Weerden, Wytske M., Nonnekens, Julie
Publicado 2022